Articles related to RESPIRATORY HEALTH

In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.

Stay informed about the latest advancements in immunization practices. Learn more about the new FDA-approved RSV vaccines and their potential impact on patient care.

ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.

Discover how engineered stem cells could revolutionize the treatment of chronic lung diseases, including pulmonary fibrosis, by offering a more personalized and sustainable approach.

Pharmacists, learn more about nirsevimab and how you can help to protect infants from RSV, the leading cause of hospitalization in infants under the age of 1.

Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.